These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33468393)

  • 1. Decreased Overall Survival in HIV-associated Non-small-cell Lung Cancer.
    Hysell K; Yusuf R; Barakat L; Virata M; Gan G; Deng Y; Perez-Irizarry J; Vega T; Goldberg SB; Emu B
    Clin Lung Cancer; 2021 Jul; 22(4):e498-e505. PubMed ID: 33468393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.
    Rengan R; Mitra N; Liao K; Armstrong K; Vachani A
    Lancet Oncol; 2012 Dec; 13(12):1203-9. PubMed ID: 23164952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer.
    Hooker CM; Meguid RA; Hulbert A; Taylor JT; Shin J; Wrangle J; Rodgers K; Lee B; Laskshmanan S; Brown T; Meneshian A; Sussman M; Keruly J; Moore RD; Yang SC; Brock MV
    Ann Thorac Surg; 2012 Feb; 93(2):405-12. PubMed ID: 22269705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals.
    Suneja G; Shiels MS; Melville SK; Williams MA; Rengan R; Engels EA
    AIDS; 2013 Jan; 27(3):459-68. PubMed ID: 23079809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.
    She Y; Jin Z; Wu J; Deng J; Zhang L; Su H; Jiang G; Liu H; Xie D; Cao N; Ren Y; Chen C
    JAMA Netw Open; 2020 Jun; 3(6):e205842. PubMed ID: 32492161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy.
    Ernani V; Appiah AK; Baine MJ; Smith LM; Ganti AK
    Cancer Treat Res Commun; 2020; 24():100197. PubMed ID: 32777751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
    Yorio JT; Yan J; Xie Y; Gerber DE
    Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy.
    Jørgensen N; Meline EL; Jeppesen SS; Hansen O; Nielsen M; Schytte T
    Acta Oncol; 2019 Oct; 58(10):1393-1398. PubMed ID: 31271075
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands.
    van der Linden N; Bongers ML; Coupé VMH; Smit EF; Groen HJM; Welling A; Schramel FMNH; Uyl-de Groot CA
    Clin Lung Cancer; 2017 Sep; 18(5):e341-e347. PubMed ID: 28347579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality among people living with HIV/AIDS with non-small-cell lung cancer in the modern HAART Era.
    Smith DM; Salters KA; Eyawo O; Franco-Villalobos C; Jabbari S; Wiseman SM; Press N; Montaner JSG; Man SFP; Hull M; Hogg RS
    AIDS Care; 2018 Jul; 30(7):936-942. PubMed ID: 29411625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort study.
    Langer C; Ravelo A; Hazard SJ; Guerin A; Ionescu-Ittu R; Latremouille-Viau D; Wu EQ; Ramalingam S
    Lung Cancer; 2014 Dec; 86(3):350-7. PubMed ID: 25439437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study.
    Makinson A; Tenon JC; Eymard-Duvernay S; Pujol JL; Allavena C; Cuzin L; Poizot-Martin I; de la Tribonnière X; Cabié A; Pugliese P; Reynes J; Le Moing V
    J Thorac Oncol; 2011 Jun; 6(6):1022-9. PubMed ID: 21512403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
    Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
    Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timeliness of Treatment Initiation and Associated Survival Following Diagnosis of Non-Small-Cell Lung Cancer in South Carolina.
    Bullard JT; Eberth JM; Arrington AK; Adams SA; Cheng X; Salloum RG
    South Med J; 2017 Feb; 110(2):107-113. PubMed ID: 28158880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy.
    Cai XW; Xu LY; Wang L; Hayman JA; Chang AC; Pickens A; Cease KB; Orringer MB; Kong FM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1100-5. PubMed ID: 19540063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
    Soares M; Antunes L; Redondo P; Borges M; Hermans R; Patel D; Grimson F; Munro R; Chaib C; Lacoin L; Daumont M; Penrod JR; O'Donnell JC; Bento MJ; Rocha Gonçalves F
    BMC Pulm Med; 2020 Sep; 20(1):240. PubMed ID: 32912174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of stereotactic body radiation therapy for biopsy-proven versus radiographically diagnosed early-stage non-small lung cancer: a single-institution experience.
    Fischer-Valuck BW; Boggs H; Katz S; Durci M; Acharya S; Rosen LR
    Tumori; 2015; 101(3):287-93. PubMed ID: 25908031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall Survival.
    Afanasjeva J; Hui RL; Spence MM; Chang J; Schottinger JE; Millares M; Rashid N
    Pharmacotherapy; 2016 Oct; 36(10):1065-1074. PubMed ID: 27521530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer.
    Raman V; Jawitz OK; Yang CJ; Voigt SL; Wang H; D'Amico TA; Harpole DH; Tong BC
    J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1680-1692.e2. PubMed ID: 31606169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.